AGBL5 Antikörper (N-Term)
Kurzübersicht für AGBL5 Antikörper (N-Term) (ABIN950299)
Target
Alle AGBL5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 106-135, N-Term
-
Spezifität
- This antibody reacts to AGBL5.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 106-135 amino acids from the N-terminal region of human AGBL5
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- AGBL5 (ATP/GTP Binding Protein-Like 5 (AGBL5))
-
Andere Bezeichnung
- AGBL5 / CCP5
-
Hintergrund
- AGBL5 has a function in the processing of cytosolic proteins such as alpha tubulin, which is known to be modified by the removal of a C terminal tyrosine. It is expressed in the brain. There are three named isoformsSynonyms: ATP/GTP-binding protein-like 5, Cytosolic carboxypeptidase-like protein 5
-
Gen-ID
- 60509
-
NCBI Accession
- NP_001030584
Target
-